focus -WSS

focus

author：Wikipedia 2025-09-28 08:32:50 - browse：99836

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Three trends to watch in biotech in 2024

knowledge

WSS

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Prime Medicine, Myeloid Therapeutics clash over genome

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Why health records don't always know when patients are dead

Risky weight loss products often used by teens globally, per study

Can sheer will power keep patients alive in their dying hours?

focus

focus

Wikipedia

Psychedelics group wrestles with new pharma identity

CRISPR gene editing developments we’re watching in 2024

Apple is now the first public company to be valued at $3 trillion

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Moonlake's readout produced a cash windfall. Risks remain

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Bright Health sells Medicare Advantage business to Molina

Doulas covered by Medicaid under New York's new plan

Medicare details structure of new drug price negotiation program

Biotech reporter’s notebook: A sunnier mood at JPM 2024

focus

Readout LOUD podcast: live from JPM 2024

Caregivers of transplant patients call for more support, training

HCA sued by state AG for quality issues at Mission Health

Keeping primary care docs in field isn't impossible, says AAFP CEO

Can sheer will power keep patients alive in their dying hours?

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

knowledge

knowledge

focus

Wikipedia